Medpace Cash Flow Statement
MEDP / Health Care|12 years of annual SEC 10-K data (FY2014-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 12 fiscal years. All figures from audited SEC 10-K filings.
Medpace generated $713M in operating cash flow and $682M in free cash flow in FY2025. Free cash flow margin was 26.9% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 147.5%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $451.1M | $404.4M | $282.8M | $145.4M | $181.8M | $145.4M | $100.4M | $13.4M | $39.1M | $13.4M | -$8.7M | -$14.3M |
| Depreciation & Amortization | - | - | - | $11.7M | - | - | - | $7.4M | - | - | $6.4M | $4.6M |
| Operating Cash Flow | $713.2M | $608.8M | $433.4M | $258.7M | $263.3M | $258.7M | $201.9M | $91.7M | $97.4M | $91.7M | $85.9M | $62.0M |
| Capital Expenditures | $31.4M | $36.5M | $36.6M | $31.3M | $28.3M | $31.3M | $17.9M | $13.5M | $11.7M | $13.5M | $6.5M | $4.2M |
| Free Cash Flow | $681.9M | $572.3M | $396.7M | $227.3M | $235.1M | $227.3M | $184.0M | $78.2M | $85.7M | $78.2M | $79.4M | $57.8M |
| Share Buybacks | $917.4M | $169.9M | $144.0M | $98.3M | $62.1M | $98.3M | $0 | $0 | $155.6M | $0 | $0 | - |
| FCF Margin | 27.0% | 27.1% | 21.0% | 24.6% | 20.6% | 24.6% | 21.4% | 18.6% | 19.6% | 18.6% | 22.1% | 23.3% |